In last trading session, InMed Pharmaceuticals Inc (NASDAQ:INM) saw 0.32 million shares changing hands with its beta currently measuring 0.60. Company’s recent per share price level of $0.25 trading at $0.0 or 0.89% at ring of the bell on the day assigns it a market valuation of $0.83M. That closing price of INM’s stock is at a discount of -732.0% from its 52-week high price of $2.08 and is indicating a premium of 16.0% from its 52-week low price of $0.21. Taking a look at company’s average trading volume volume of 881.49K if we extend that period to 3-months.
For InMed Pharmaceuticals Inc (INM), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
InMed Pharmaceuticals Inc (NASDAQ:INM) trade information
Upright in the green during last session for gaining 0.89%, in the last five days INM remained trading in the red while hitting it’s week-highest on Friday, 06/28/24 when the stock touched $0.25 price level, adding 10.68% to its value on the day. InMed Pharmaceuticals Inc’s shares saw a change of -39.90% in year-to-date performance and have moved -4.94% in past 5-day. InMed Pharmaceuticals Inc (NASDAQ:INM) showed a performance of -18.11% in past 30-days.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 39.17% during past 5 years.
INM Dividends
InMed Pharmaceuticals Inc is more likely to be releasing its next quarterly report in August and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
